Global Hydroxyapatite Market: Continuous R&D activities to increase applicability of hydroxyapatite in medical industry is driving the market.

Published Date: 14/05/2021

The Hydroxyapatite (HAp) market is projected to grow from USD 2.20 billion in 2020 to USD 3.46 billion by 2027, at a CAGR of 6.7 % between 2020 and 2027. Hydroxyapatite, the mineral form of calcium apatite, consists of one phosphate and one hydroxyl group. It is a major component of teeth offering high rigidity and better enamel remineralization than saliva. Hydroxyapatite coatings in orthopedic implants and dental care products offer enhanced properties, including increased gap healing between bone and hydroxyapatite, faster bone healing at the bone-implant interface, and corrosion inhibition. Thus, manufacturers are replacing conventional titanium plasma spray coatings with nano-hydroxyapatite coatings.

The growth of the global hydroxyapatite materials market is driven by increase in demand for bone transplants and bone grafting materials. In addition, growing population of elderly people in the countries, such as the U.S. and Canada, further fuels the demand for orthopedic implants; there, boosting the hydroxyapatite market growth. For instance, in the U.S., population of elderly people increased by 33% over the past 10 years. Furthermore, rise in disposable income in emerging nations and developed countries fuels to growth of the cosmetics products, such as anti-aging and skin care products.

This sudden surge in demand leads to increase in product portfolio and manufacturing facilities across the globe; thereby, enhancing the hydroxyapatite market share. Moreover, introduction of new healthcare services in North America and European countries is anticipated to fuel the growth of the hydroxyapatite market size. Countries in North America and Europe are spending 11-15% of their GDP in healthcare and research institutes; thus, fueling the growth of the market.

For instance, in 2018, the U.S. increased healthcare expenditure of around 4.6%. Furthermore, advancements in product quality led to superior dental and orthopedic implants. For instance, hydroxyapatite, prepared through advanced sol-gel process, provides advantages in terms of particle size and coating formation, making it widely applicable for ocular implant and non-integrated implants. However, high cost of hydroxyapatite implant and several complications involved in the implant are expected to hamper the market growth.

The high cost associated with the implant and additional cost of wrapping the material and peg replacement may led to increase in demand for porous implants with reduced cost and less complications. Conversely, development of low-cost hydroxyapatite implants, such as synthetic hydroxyapatite implants, attracts new customer segments in North American countries; thereby, providing lucrative opportunities for the market growth.

The major players in the Hydroxyapatite market are unfavorable healthcare reforms in the US and unmet performance benchmark by hydroxyapatite such as its low fracture toughness. The key players operating in the Hydroxyapatite market are FLUIDINOVA (Portugal), SofSera Corporation (Japan), Berkeley Advanced Biomaterials (US), Taihei Chemical Industrial Co. Ltd. (Japan), SigmaGraft (US) and CAM Bioceramics (Netherlands).

It is projected to register significant growth in the Hydroxyapatite market during the forecast period as well. The Asia Pacific Hydroxyapatite market is projected to grow at the highest CAGR during the forecast period. The increased demand for hydroxyapatite from countries such as China, South Korea, and South Korea is driving the growth of the Asia Pacific Hydroxyapatite market. Moreover, the aging population, increasing disposable income of the middle-class population, and growing awareness among masses about the advantages of dental bone grafting and bone grafting over traditional treatments provide a huge growth opportunity for the manufacturers of hydroxyapatite in the Asia Pacific region.